Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Take Heart America is an international cardiac arrest survival initiative and non-profit organization dedicated to increasing neurologically intact survival rates from sudden cardiac arrest (SCA). Founded in 2005 by Dr. Keith Lurie and Robert Niskanen, the organization promotes a comprehensive "Bundle of Care" known as the Neuroprotective CPR Strategy (NCPR). This strategy integrates advanced resuscitation technologies—such as the Impedance Threshold Device (ITD), active compression-decompression CPR, and head-up CPR—with coordinated protocols across the chain of survival. Take Heart America works with communities, EMS agencies, and hospitals to implement these data-driven life-saving measures and hosts an annual conference to advance resuscitation science.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Take Heart America.